Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 130,290 |
|
|||||
| News | - | ||||||
| Day High | 3.04 | Low High |
|||||
| Day Low | 2.74 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Turnstone Biologics Corporation | TSBX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.146 | -5.03% | 2.754 | 18:15:09 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.88 | 2.74 | 3.04 | 2.76 | 2.90 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 904 | 130,290 | $ 2.87 | $ 373,722 | - | 1.625 - 13.20 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:15:09 | 1 | $ 2.75 | USD |
Turnstone Biologics Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 63.74M | 23.09M | - | 19.31M | -55.2M | -2.39 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Turnstone Biologics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TSBX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.71 | 3.19 | 2.56 | 2.90 | 111,114 | 0.044 | 1.62% |
| 1 Month | 2.75 | 3.8782 | 2.56 | 3.13 | 191,916 | 0.004 | 0.15% |
| 3 Months | 2.77 | 5.75 | 2.00 | 3.21 | 173,675 | -0.016 | -0.58% |
| 6 Months | 2.25 | 5.75 | 1.625 | 3.00 | 138,992 | 0.504 | 22.40% |
| 1 Year | 11.40 | 13.20 | 1.625 | 3.99 | 122,618 | -8.65 | -75.84% |
| 3 Years | 11.40 | 13.20 | 1.625 | 3.99 | 122,618 | -8.65 | -75.84% |
| 5 Years | 11.40 | 13.20 | 1.625 | 3.99 | 122,618 | -8.65 | -75.84% |
Turnstone Biologics Description
| Turnstone Biologics Corp. is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The Company is focused on developing tumor infiltrating lymphocytes (TIL) therapies designed to drive clinical benefit and curative outcomes across multiple solid tumors. Its selected TIL approach focuses on selecting and expanding potent tumor-reactive T cells to overcome the limitations of bulk TILs. Its pipeline includes TIDAL-01 and TIDAL-02. Its lead selected TIL product candidate, TIDAL-01, utilizes an unbiased identification and functional screening process to isolate and selectively expand the breadth of tumor-reactive TILs from the patient¿s tumor. Its next selected TIL program, TIDAL-02, is being designed to encompass a streamlined manufacturing process for tumor-reactive T cells and additional modifications to enhance TIL quality and function. |
